Mochida, Satoshi

Publishing since 2000 (Senior)

Has published 31 publications in 10 years

Number of publications published per year by Mochida, Satoshi. (Source : PubMed)

Distribution of publications types for Mochida, Satoshi. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.  Nat. Genet.  2009;41;10  
•  Hashikura Y, Ichida T, Umeshita K, Kawasaki S, Mizokami M, Mochida S, Yanaga K, Monden M, Kiyosawa K. Donor complications associated with living donor liver transplantation in Japan.  Transplantation  2009;88;1  
•  Kusakabe A, Tanaka Y, Mochida S, Nakayama N, Inoue K, Sata M, Isoda N, Kang JH, Sumino Y, Yatsuhashi H, Takikawa Y, Kaneko S, Yamada G, Karino Y, Tanaka E, Kato J, Sakaida I, Izumi N, Sugauchi F, Nojiri S, Joh T, Miyakawa Y, Mizokami M. Case-control study for the identification of virological factors associated with fulminant hepatitis B.  Hepatol. Res.  2009;39;7  
•  Shindo M, Chayama K, Mochida S, Toyota J, Tomita E, Kumada H, Yokosuka O, Sata M, Hayashi N, Suzuki K, Okanoue T, Tsubouchi H, Ishikawa H, Seriu T, Omata M. Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial.  Hepatology international  2009  
•  Nakashima S, Ota S, Arai S, Yoshino K, Inao M, Ishikawa K, Nakayama N, Imai Y, Nagoshi S, Mochida S. Usefulness of anti-ulcer drugs for the prevention and treatment of peptic ulcers induced by low doses of aspirin.  World J. Gastroenterol.  2009;15;6  
•  Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis.  Hepatol. Res.  2008;38;10  
•  Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G. Fulminant hepatitis and late onset hepatic failure in Japan.  Hepatol. Res.  2008;38;7  
•  Miura N, Kabashima H, Shimizu M, Sato R, Tsukamoto T, Harada T, Takahashi S, Endo R, Nakayama N, Takikawa Y, Mochida S, Suzuki K, Hasegawa J, Shiota G. Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis.  Hepatology international  2008;2;2  
•  Sugiyama M, Tanaka Y, Kurbanov F, Nakayama N, Mochida S, Mizokami M. Influences on hepatitis B virus replication by a naturally occurring mutation in the core gene.  Virology  2007;365;2  
•  Fujiwara K, Kaneko S, Kakumu S, Sata M, Hige S, Tomita E, Mochida S. Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load.  Hepatol. Res.  2007;37;9  

[ See timeline ] [ See all publications ]